Search
Patexia Research
Case number 2019-2255

Bio-Rad Laboratories, Inc. v. 10X Genomics Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 BIO-RAD LABORATORIES, INC. v. 10X GENOMICS INC. [OPINION] [precedential] (0)
Nov 12, 2020 70 Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [734977] [19-2255, 19-2285] [MJL] [Entered: 11/12/2020 09:01 AM] (1)
Nov 4, 2020 69 ORDER filed denying [62] petition for en banc rehearing filed by 10X Genomics Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [733472] [JAB] [Entered: 11/04/2020 08:36 AM] (2)
Oct 19, 2020 68 18 paper copies of Doc. No. [67] received from Amici Curiae Electronic Frontier Foundation and R Street Institute. [730111] [VDW] [Entered: 10/20/2020 10:09 AM] (0)
Oct 16, 2020 67 AMICUS BRIEF FILED on Petition by Electronic Frontier Foundation and R Street Institute. Service: 10/15/2020 by email. [729419] [MJL] [Entered: 10/16/2020 01:54 PM] (20)
Oct 16, 2020 66 ORDER filed granting EFF and R Street Institute's motion [64] for leave to file an amicus brief in supporting of the petition for rehearing en banc. By: Per Curiam. Service as of this date by the Clerk of Court. [729417] [MJL] [Entered: 10/16/2020 01:52 PM] (2)
Oct 15, 2020 65 Certificate of Interest for Electronic Frontier Foundation and R Street Institute. Service: 10/15/2020 by email. [729230] [19-2255] [Alexandra Moss] [Entered: 10/15/2020 09:03 PM] (3)
Oct 15, 2020 64 MOTION of Electronic Frontier Foundation and R Street Institute as amici curiae for leave to file amicus brief in support of IN SUPPORT OF THE PETITION FOR REHEARING EN BANC on petition for en banc rehearing [62]. Service: 10/15/2020 by email. [729229] [19-2255] [Alexandra Moss] [Entered: 10/15/2020 09:01 PM] (26)
Oct 15, 2020 63 Entry of appearance for Alexandra H. Moss; Charles Duan as counsel for Electronic Frontier Foundation; R Street Institute. Service: 10/15/2020 by email. [729227] [19-2255] [Alexandra Moss] [Entered: 10/15/2020 08:32 PM] (1)
Oct 2, 2020 62 Petition for en banc rehearing filed by Appellant 10X Genomics Inc.. Service: 10/02/2020 by email. [726214] [19-2255] [E. Rosenkranz] [Entered: 10/02/2020 03:02 PM] (72)
Aug 11, 2020 61 ORDER filed granting motion to extend time to file petition for rehearing/en banc [60] filed by Appellant 10X Genomics Inc. Petition for Rehearing due on or before 10/02/2020. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [714144] [JAB] [Entered: 08/11/2020 12:37 PM] (2)
Aug 10, 2020 60 MOTION of Appellant 10X Genomics Inc. to extend the time to file a Petition for Rehearing En Banc until 10/02/2020 [Consent: unopposed]. Service: 08/10/2020 by email. [713931] [19-2255] [E. Rosenkranz] [Entered: 08/10/2020 06:49 PM] (7)
Aug 3, 2020 59 JUDGMENT. AFFIRMED-IN-PART, REVERSED-IN-PART, VACATED-IN-PART, AND REMANDED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [711800] [19-2255, 19-2285] [JAB] [Entered: 08/03/2020 10:10 AM] (1)
Aug 3, 2020 58 OPINION filed for the court by Newman, Circuit Judge; O'Malley, Circuit Judge and Taranto, Circuit Judge. Precedential Opinion. [711799] [19-2255, 19-2285] [JAB] [Entered: 08/03/2020 10:09 AM] (39)
Apr 10, 2020 57 Submitted after ORAL ARGUMENT by Mr. E. Joshua Rosenkranz for 10X Genomics Inc. and Edward R. Reines for University of Chicago and Bio-Rad Laboratories, Inc. Panel: Judge: Newman , Judge: O'Malley , Judge: Taranto. [685892] [JCP] [Entered: 04/10/2020 10:20 AM] (0)
Mar 26, 2020 56 Clerk's Letter to Appellant 10X Genomics Inc. and Appellees Bio-Rad Laboratories, Inc. and University of Chicago (April 2020 Telephonic Argument Orientation). Service as of this date by the Clerk of Court. [682119] [JBP] [Entered: 03/26/2020 03:14 PM] (0)
Mar 12, 2020 55 ORDER filed. The court will conduct argument in this case by telephone at the originally scheduled date and time in lieu of in-person appearance. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [678248] [MJL] [Entered: 03/12/2020 12:01 PM] (2)
Feb 27, 2020 54 Response to notice of oral argument from the Appellant 10X Genomics Inc.. [674926] [19-2255] [E. Rosenkranz] [Entered: 02/27/2020 03:28 PM] (3)
Feb 27, 2020 53 Response to notice of oral argument from the Appellees Bio-Rad Laboratories, Inc. and University of Chicago. [674850] [19-2255] [Edward Reines] [Entered: 02/27/2020 01:59 PM] (3)
Feb 21, 2020 52 NOTICE OF ORAL ARGUMENT. Panel: 2004M. Case scheduled April 10, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 03/16/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [673328] [JAB] [Entered: 02/21/2020 02:47 PM] (2)
Jan 31, 2020 51 The following conflict dates submitted by Attorney E. Joshua Rosenkranz for Appellant 10X Genomics Inc. have been accepted by the court: 04/06/2020, 04/07/2020. [667483] [JAB] [Entered: 01/31/2020 08:12 AM] (0)
Jan 27, 2020 50 Notice from Appellant 10X Genomics Inc. regarding conflicts with oral argument. Service: 01/27/2020 by email. [666126] [19-2255] [E. Rosenkranz] [Entered: 01/27/2020 01:11 PM] (5)
Jan 24, 2020 49 6 paper copies of the Amicus Brief [31] received from Amicus Curiae Broad Institute, Inc. [665769] [CJF] [Entered: 01/24/2020 10:29 AM] (0)
Jan 24, 2020 48 6 paper copies of the Confidential Joint Appendix (Vol. I - IV) [37] received from Appellant 10X Genomics Inc. [665768] [CJF] [Entered: 01/24/2020 10:28 AM] (0)
Jan 24, 2020 47 6 paper copies of the Reply Brief [33] received from Appellant 10X Genomics Inc. [665767] [CJF] [Entered: 01/24/2020 10:27 AM] (0)
Jan 24, 2020 46 6 paper copies of the Opening Brief [24] received from Appellant 10X Genomics Inc. [665766] [CJF] [Entered: 01/24/2020 10:26 AM] (0)
Jan 23, 2020 45 6 paper copies of the Opening Response Brief [32] received from Appellees Bio-Rad Laboratories, Inc. and University of Chicago. [665706] [CJF] [Entered: 01/24/2020 07:45 AM] (0)
Jan 22, 2020 44 Notice from Appellees Bio-Rad Laboratories, Inc. and University of Chicago regarding conflicts with oral argument. None. Service: 01/22/2020 by email. [665207] [19-2255] [Edward Reines] [Entered: 01/22/2020 04:22 PM] (0)
Jan 22, 2020 43 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session month listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [665129] [JAL] [Entered: 01/22/2020 01:12 PM] (1)
Jan 22, 2020 42 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [665127] [JAL] [Entered: 01/22/2020 01:11 PM] (0)
Jan 22, 2020 41 ORDER filed granting motion to schedule oral argument [40] filed by Appellees University of Chicago, Bio-Rad Laboratories, Inc. and Appellant 10X Genomics Inc.; denying as moot motion to schedule oral argument [35] filed by Appellees University of Chicago, Bio-Rad Laboratories, Inc. and Appellant 10X Genomics Inc. Service as of this date by the Clerk of Court. [665078] [NL] [Entered: 01/22/2020 11:57 AM] (2)
Dec 26, 2019 36 MODIFIED ENTRY: JOINT APPENDIX FILED for Appellant 10X Genomics Inc. Number of Pages: 2003. Service: 12/26/2019 by email. [658956] --[Edited 12/31/2019 by JAL - Compliance review complete] [E. Rosenkranz] [Entered: 12/26/2019 04:03 PM] (2003)
Dec 26, 2019 37 MODIFIED ENTRY: CONFIDENTIAL JOINT APPENDIX FILED for Appellant 10X Genomics Inc. Number of Pages: 2126. Service: 12/26/2019 by email. [658959]--[Edited 12/31/2019 by JAL - Compliance review complete] [E. Rosenkranz] [Entered: 12/26/2019 04:17 PM] (0)
Dec 26, 2019 38 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant 10X Genomics Inc. and Appellees Bio-Rad Laboratories, Inc. and University of Chicago. Service: 12/26/2019 by email. [658960] [19-2255] [E. Rosenkranz] [Entered: 12/26/2019 04:21 PM] (3)
Dec 26, 2019 39 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant 10X Genomics Inc.. Service: 12/26/2019 by email. [658961] [19-2255] [E. Rosenkranz] [Entered: 12/26/2019 04:25 PM] (3)
Dec 26, 2019 40 MOTION of Appellant 10X Genomics Inc. and Appellees Bio-Rad Laboratories, Inc. and University of Chicago to schedule oral argument [Consent: unopposed]. Service: 12/26/2019 by email. [658966] [19-2255] [E. Rosenkranz] [Entered: 12/26/2019 04:56 PM] (6)
Dec 20, 2019 35 MOTION of Appellees Bio-Rad Laboratories, Inc., University of Chicago and Appellant 10X Genomics Inc. to schedule oral argument [Consent: unopposed]. Service: 12/20/2019 by email. [658355] [19-2255] [Edward Reines] [Entered: 12/20/2019 06:09 PM] (8)
Dec 18, 2019 33 MODIFIED ENTRY: REPLY BRIEF FILED for Appellant 10X Genomics Inc. Number of Pages: 39. Service: 12/18/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [657649] --[Edited 12/19/2019 by JAL - Compliance review complete] [E. Rosenkranz] [Entered: 12/18/2019 05:09 PM] (48)
Dec 18, 2019 34 Amended Certificate of Interest for Appellant 10X Genomics Inc.. Service: 12/18/2019 by email. [657650] [19-2255] [E. Rosenkranz] [Entered: 12/18/2019 05:13 PM] (2)
Nov 27, 2019 32 MODIFIED ENTRY: RESPONSE BRIEF FILED for Appellees Bio-Rad Laboratories, Inc. and University of Chicago. Number of Pages: 68. Service: 11/27/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [653011] --[Edited 12/04/2019 by JAL - Compliance review complete] [Edward Reines] [Entered: 11/27/2019 07:21 PM] (79)
Nov 19, 2019 31 AMICUS BRIEF FILED for Amicus Curiae The Broad Institute, Inc. Pages: 32. Service: 11/19/2019 by clerk. [650510] [JAL] [Entered: 11/19/2019 12:16 PM] (40)
Nov 19, 2019 30 ORDER filed granting motion for leave to file an amicus curiae brief [27]. The brief is accepted for filing. Service as of this date by the Clerk of Court. [650501] [LMS] [Entered: 11/19/2019 11:55 AM] (2)
Nov 1, 2019 29 RESPONSE of Appellees Bio-Rad Laboratories, Inc. and University of Chicago to the motion [27]. Service: 11/01/2019 by email. [646491] [19-2255] [Edward Reines] [Entered: 11/01/2019 04:50 PM] (6)
Oct 28, 2019 28 ORDER expediting a response to the motion for leave to file an amicus curiae brief [27]. Any opposition to the motion shall be filed no later than seven days from the date of issuance of this order. Any reply is due no later than three days from the date of filing of the response. Service as of this date by the Clerk of Court. [645169] [NL] [Entered: 10/28/2019 01:55 PM] (2)
Oct 25, 2019 27 MOTION of The Broad Institute, Inc. for leave to file an amicus curiae brief [Consent: partial consent]. Service: 10/25/2019 by email. [644902] [19-2255] [Steven Trybus] [Entered: 10/25/2019 04:04 PM] (56)
Oct 25, 2019 26 Certificate of Interest for The Broad Institute, Inc.. Service: 10/25/2019 by email. [644842] [19-2255] [Steven Trybus] [Entered: 10/25/2019 02:47 PM] (2)
Oct 25, 2019 25 Entry of appearance for Steven R. Trybus as principal counsel for The Broad Institute, Inc.. Service: 10/25/2019 by email. [644838] [19-2255] [Steven Trybus] [Entered: 10/25/2019 02:45 PM] (1)
Oct 18, 2019 24 MODIFIED ENTRY: OPENING BRIEF FILED for Appellant 10X Genomics Inc. Number of Pages: 79. Service: 10/18/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [643282] --[Edited 10/21/2019 by JAL - Compliance review complete] [E. Rosenkranz] [Entered: 10/18/2019 07:46 PM] (452)
Sep 24, 2019 23 ORDER filed granting motion [629412-2] to the extent provided herein. Service as of this date by the Clerk of Court. [637752] [19-2255, 19-2285] [LMS] [Entered: 09/24/2019 12:24 PM] (3)
Sep 19, 2019 22 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [636773] [JAL] [Entered: 09/19/2019 12:01 PM] (0)
Aug 27, 2019 21 REPLY of Appellant 10X Genomics Inc. to response [18]. Service: 08/27/2019 by clerk. [631449] [JAL] [Entered: 08/27/2019 05:04 PM] (23)
Aug 26, 2019 20 ORDER filed. The request for an interim stay is granted to the extent that 10x Genomics may continue to sell the Linked-Reads and CNV products subject to the royalty and deposit requirements set forth in Section III of the district court's injunction order while the court considers the motion papers. Service as of this date by the Clerk of Court. [631086] [19-2255, 19-2285] [JAL] [Entered: 08/26/2019 04:15 PM] (2)
Aug 26, 2019 19 Confidential Addendum To Opposition To Motion To Stay Permanent Injunction Pending Appeal filed by Appellees Bio-Rad Laboratories, Inc. and University of Chicago corresponding to Doc. No. [18]. Service: 08/25/2019 by email. [630745] [19-2255] [Edward Reines] [Entered: 08/26/2019 02:46 AM] (0)
Aug 26, 2019 18 MODIFIED ENTRY: RESPONSE of Appellees Bio-Rad Laboratories, Inc. and University of Chicago to the motion for an emergency stay pending appeal under Rule 8/18 [629412-2]. Service: 08/25/2019 by email. [630744]--[Edited 08/26/2019 by JCA - Reason: to correct filing event] [Edward Reines] [Entered: 08/26/2019 02:40 AM] (122)
Aug 23, 2019 17 Entry of appearance for Robert L. Gerrity as of counsel for Appellant 10X Genomics Inc.. Service: 08/23/2019 by email. [630682] [19-2255] [Robert Gerrity] [Entered: 08/23/2019 02:58 PM] (2)
Aug 23, 2019 16 Entry of appearance for Azra M. Hadzimehmedovic as of counsel for Appellant 10X Genomics Inc.. Service: 08/23/2019 by email. [630681] [19-2255] [Azra Hadzimehmedovic] [Entered: 08/23/2019 02:55 PM] (2)
Aug 23, 2019 15 Entry of appearance for Matthew D. Powers as of counsel for Appellant 10X Genomics Inc.. Service: 08/23/2019 by email. [630680] [19-2255] [Matthew Powers] [Entered: 08/23/2019 02:48 PM] (2)
Aug 23, 2019 14 Docketing Statement for the Appellees Bio-Rad Laboratories, Inc. and University of Chicago. Service: 08/23/2019 by email. [630675] [19-2255] [Edward Reines] [Entered: 08/23/2019 02:33 PM] (3)
Aug 23, 2019 13 Certificate of Interest for Appellees Bio-Rad Laboratories, Inc. and University of Chicago. Service: 08/23/2019 by email. [630674] [19-2255] [Edward Reines] [Entered: 08/23/2019 02:32 PM] (3)
Aug 23, 2019 12 Entry of appearance for Christopher S. Lavin as of counsel for Appellees Bio-Rad Laboratories, Inc. and University of Chicago. Service: 08/23/2019 by email. [630672] [19-2255] [Edward Reines] [Entered: 08/23/2019 02:30 PM] (2)
Aug 23, 2019 11 Entry of appearance for Derek C. Walter as of counsel for Appellees Bio-Rad Laboratories, Inc. and University of Chicago. Service: 08/23/2019 by email. [630669] [19-2255] [Edward Reines] [Entered: 08/23/2019 02:29 PM] (2)
Aug 23, 2019 10 Entry of appearance for Edward R. Reines as principal counsel for Appellees Bio-Rad Laboratories, Inc. and University of Chicago. Service: 08/23/2019 by email. [630666] [19-2255] [Edward Reines] [Entered: 08/23/2019 02:28 PM] (2)
Aug 23, 2019 9 Docketing Statement for the Appellant 10X Genomics Inc.. Service: 08/23/2019 by email. [630594] [19-2255] [E. Rosenkranz] [Entered: 08/23/2019 10:53 AM] (3)
Aug 23, 2019 8 Certificate of Interest for Appellant 10X Genomics Inc.. Service: 08/23/2019 by email. [630590] [19-2255] [E. Rosenkranz] [Entered: 08/23/2019 10:52 AM] (3)
Aug 23, 2019 7 Entry of appearance for Elizabeth R. Moulton as of counsel for Appellant 10X Genomics Inc.. Service: 08/23/2019 by email. [630583] [19-2255] [Elizabeth Moulton] [Entered: 08/23/2019 10:50 AM] (2)
Aug 23, 2019 6 Entry of appearance for Melanie L. Bostwick as of counsel for Appellant 10X Genomics Inc.. Service: 08/23/2019 by email. [630581] [19-2255] [Melanie Bostwick] [Entered: 08/23/2019 10:48 AM] (2)
Aug 23, 2019 5 Entry of appearance for E. Joshua Rosenkranz as principal counsel for Appellant 10X Genomics Inc.. Service: 08/23/2019 by email. [630577] [19-2255] [E. Rosenkranz] [Entered: 08/23/2019 10:45 AM] (2)
Aug 22, 2019 4 ORDER filed expediting any response to the motion [629412-2] shall be filed no later than 9:00 a.m. on August 26, 2019. Any reply in support of the motion is due no later than 5:00 p.m. on August 27, 2019. (Per Curiam). Service as of this date by the Clerk of Court. [630162] [19-2255, 19-2285] [LMS] [Entered: 08/22/2019 10:43 AM] (2)
Aug 20, 2019 3 Note to file: The following cases are associated: 19-2255 Lead with 19-2285 Member Case. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [629582] [19-2255, 19-2285] [JAL] [Entered: 08/20/2019 12:43 PM] (0)
Aug 20, 2019 2 ORDER consolidating appeals (19-2255 with 19-2285). The revised official caption is reflected in the order. The appellant’s opening brief is due no later than October 18, 2019. Service as of this date by the Clerk of Court. [629567] [19-2255, 19-2285] [NL] [Entered: 08/20/2019 12:22 PM] (2)
Aug 9, 2019 1 Appeal docketed. Received: 08/09/2019. [627276]Entry of Appearance is due 08/23/2019. Certificate of Interest is due on 08/23/2019. Docketing Statement is due 08/23/2019. Appellant's brief is due 10/08/2019. [JAL] [Entered: 08/09/2019 12:57 PM] (49)
Menu